S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
All the trading advice you’ve ever received boils down to this (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
All the trading advice you’ve ever received boils down to this (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
All the trading advice you’ve ever received boils down to this (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way

Tonix Pharmaceuticals (TNXP) News Today

$0.40
+0.02 (+5.29%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.38
$0.42
50-Day Range
$0.38
$0.59
52-Week Range
$0.37
$9.81
Volume
2.27 million shs
Average Volume
820,144 shs
Market Capitalization
$9.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
SourceHeadline
MarketBeat logoZacks Small Cap Weighs in on Tonix Pharmaceuticals Holding Corp.'s FY2023 Earnings (NASDAQ:TNXP)
americanbankingnews.com - December 9 at 1:40 AM
msn.com logoTonix stock climbs as PWS therapy cleared for clinical studies
msn.com - December 5 at 1:23 PM
MarketBeat logoTonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - December 3 at 1:22 AM
proactiveinvestors.com logoTonix Pharmaceuticals' CEO Reveals Next-Generation COVID Vaccine Technology chosen for key program
proactiveinvestors.com - November 17 at 11:32 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Enrollment Initiated in Mass General Brigham Phase 2 Investigator-Initiated Study of TNX-1900 (Intranasal Potentiated Oxytocin) for Bone Health in Children with Autism Spectrum Disorder
finance.yahoo.com - November 13 at 8:43 AM
finance.yahoo.com logoTonix Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - November 9 at 7:00 PM
benzinga.com logoWhy Tonix Pharmaceuticals (TNXP) Stock Is Falling Sharply Today
benzinga.com - November 1 at 1:08 PM
marketwatch.com logoTonix to Stop Development of Depression Treatment After Study Results
marketwatch.com - October 31 at 8:14 PM
marketwatch.com logoTonix Shares Sink 29% on Discontinued Development on Depression Treatment
marketwatch.com - October 31 at 8:14 PM
msn.com logoTonix pulls plug on drug TNX-601 ER for depression, stock plunges 35%
msn.com - October 31 at 8:14 PM
marketbeat.com logo
marketbeat.com - October 31 at 4:55 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces New Data Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) in Heart Xenotransplantation in Animal Models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress
finance.yahoo.com - October 30 at 7:45 AM
finanznachrichten.de logoTonix Pharmaceuticals: New Hope for Long COVID Sufferers
finanznachrichten.de - October 27 at 6:44 PM
proactiveinvestors.com logoTonix Pharmaceuticals expects topline results from migraine prevention study in December
proactiveinvestors.com - October 26 at 10:16 AM
finance.yahoo.com logoNew Hope for Long COVID Sufferers
finance.yahoo.com - October 25 at 1:09 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Publication of Data in the Journal Nature Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) for the Prevention of Rejection in Kidney Xenotransplantation in Animal Models
finance.yahoo.com - October 18 at 7:41 AM
finance.yahoo.com logoTonix Pharmaceuticals Completes Clinical Stage of Phase 2 UPLIFT Study of TNX-601 ER for the Treatment of Major Depressive Disorder
finance.yahoo.com - October 16 at 7:49 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe
finance.yahoo.com - October 11 at 9:47 AM
finance.yahoo.com logoTonix Pharmaceuticals Provides Overview of TNX-2900 Program for the Treatment of Prader-Willi Syndrome at the Foundation for Prader-Willi Research Family Conference
finance.yahoo.com - October 9 at 8:02 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Issuance of EU Patent Covering Intranasal Potentiated Oxytocin (TNX-1900) for the Treatment of Pain
finance.yahoo.com - October 4 at 9:32 AM
benzinga.com logoWhy Tonix Pharmaceuticals (TNXP) Shares Are Getting Obliterated
benzinga.com - September 30 at 9:58 AM
marketwatch.com logoTonix Pharmaceuticals Shares Tumble Premarket on Stock Sale
marketwatch.com - September 29 at 8:23 AM
markets.businessinsider.com logoTonix Pharma: Department Of Defense To Support Proposed Investigator Sponsored OASIS Trial
markets.businessinsider.com - September 27 at 1:30 PM
finance.yahoo.com logoTNXP: Encouraging Topline Results for Long COVID Trial…
finance.yahoo.com - September 26 at 2:38 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Presentation of Non-Clinical Studies Supporting the Mechanism of TNX-1900 (Intranasal Potentiated Oxytocin) at the 2023 International Headache Congress
finance.yahoo.com - September 18 at 9:22 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700 in Preclinical Colorectal Cancer Models at the Seventh International Cancer Immunotherapy Conference 2023
finance.yahoo.com - September 14 at 8:52 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Commitment to Supply Tosymra® (sumatriptan Nasal Spray) 10 mg for Treatment of Acute Migraine to Meet Potential Increased Demand Following GSK’s Planned Discontinuation of Imitrex® (sumatriptan) Nasal Spray After January 2024
finance.yahoo.com - September 6 at 10:00 AM
marketwatch.com logoTonix Pharma Shares Drop 11% After Covid Treatment Trial Misses Endpoint
marketwatch.com - September 5 at 4:33 PM
msn.com logoWhy Is Tonix Pharmaceuticals Stock Trading Lower Today?
msn.com - September 5 at 4:33 PM
marketwatch.com logoTonix Pharmaceuticals: Topline Results for TNX-102 SL Miss Primary Endpoint
marketwatch.com - September 5 at 8:12 AM
reuters.com logoTonix's long COVID drug fails to meet mid-stage trial goal
reuters.com - September 5 at 8:12 AM
markets.businessinsider.com logoTonix Pharma Reports Topline Results From Phase 2 PREVAIL Proof-of-Concept Study Of TNX-102 SL
markets.businessinsider.com - September 5 at 8:12 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Topline Results from Phase 2 PREVAIL Proof-of-Concept Study of TNX-102 SL for the Management of Fibromyalgia-Type Long COVID
finance.yahoo.com - September 5 at 8:12 AM
finance.yahoo.com logoUPDATE 1-Tonix's long COVID drug fails to meet mid-stage trial goal
finance.yahoo.com - September 5 at 8:12 AM
proactiveinvestors.com logoTonix Pharmaceuticals announces company is looking to...Tonix Pharmaceuticals announces company is looking to accelerate...
proactiveinvestors.com - August 29 at 4:24 PM
finance.yahoo.com logoTonix Pharmaceuticals begins Phase 1 trial of TNX-1500 in healthy participants
finance.yahoo.com - August 21 at 4:34 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-801 as a Potential Vaccine to Prevent Mpox and Smallpox
finance.yahoo.com - August 21 at 9:23 AM
finanznachrichten.de logoTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights
finanznachrichten.de - August 11 at 6:38 AM
finance.yahoo.com logoTonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - August 11 at 1:37 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Enrollment Initiated in the MGH Phase 2 ‘STROBE’ Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the Treatment of Binge-Eating Disorder
finance.yahoo.com - July 31 at 9:58 AM
benzinga.com logoWhy Tonix Pharmaceuticals Stock Is Getting Obliterated
benzinga.com - July 28 at 2:04 PM
finanznachrichten.de logoTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Proposed Public Offering
finanznachrichten.de - July 28 at 9:03 AM
finanznachrichten.de logoTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering
finanznachrichten.de - July 28 at 9:03 AM
seekingalpha.com logoTonix Pharmaceuticals stock sinks on pricing $7M public offering
seekingalpha.com - July 28 at 9:03 AM
marketwatch.com logoTonix Pharmaceuticals Shares Slide Premarket on Public Offering
marketwatch.com - July 28 at 9:03 AM
msn.com logoWhy Is Tonix Pharmaceuticals (TNXP) Stock Down 43% Today?
msn.com - July 28 at 9:03 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Accelerating Completion of Enrollment in Phase 2 UPLIFT Study of TNX-601 ER (Racemic Tianeptine) for Major Depressive Disorder: Topline Data Now Expected in Fourth Quarter 2023
finance.yahoo.com - July 26 at 8:42 PM
finance.yahoo.com logoTonix Pharmaceuticals Announces Data Supporting the Memory- and Cognition-Enhancing Effects of Racemic Tianeptine and (S)-Tianeptine, but not (R)-Tianeptine, in the In Vivo Rat Novel Object Recognition (NOR) Test
finance.yahoo.com - July 24 at 7:51 AM
finance.yahoo.com logoTonix Pharmaceuticals Announces Agreement and Initiation of Enrollment in Phase 2 Trial with the University of Washington to Study TNX-1900 (Potentiated Intranasal Oxytocin) for Social Anxiety Disorder
finance.yahoo.com - July 17 at 9:31 AM
proactiveinvestors.com logoTonix Pharmaceuticals acquires pair of FDA-approved migraine products from Upsher-Smith
proactiveinvestors.com - July 7 at 10:27 AM
Get Tonix Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter.



TNXP Media Mentions By Week

TNXP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNXP
News Sentiment

-0.47

0.52

Average
Medical
News Sentiment

TNXP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNXP Articles
This Week

5

1

TNXP Articles
Average Week

Get Tonix Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TNXP) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -